The curves showed that high expression levels of GPX2, CANX, SLPI, CFL1 and PIGO in patients were significantly associated with lower overall survival than those in low expression groups, which correlated with worse survival rates in HCC patients. Here, PIGO is linked to hepatocellular carcinoma.